Skip to main content
. 2010 Jan 8;92(1):286–295. doi: 10.3168/jds.2008-1433

Table 6.

Results from a multivariate GLM1 modeling 28-d ADG in 3 field trials (ranches A, B, and C) evaluating the efficacy of feeding a colostrum supplement in milk replacer for 14 d to preweaned calves (n = 235)

Variable Level LSM Estimate,2 kg P-value 90% CI3
Lower Upper
Treatment group4 CS 0.24 0.04 0.22 0.27
PS 0.22 0.39 0.19 0.25
UC 0.20 Reference 0.17 0.23
Serum IgG category5 FPT 0.15 <0.01 0.11 0.20
PFPT 0.24 0.12 0.21 0.26
APT 0.27 Reference 0.25 0.29
Weight category6 Low 0.27 <0.01 0.24 0.30
Mid 0.23 <0.01 0.20 0.25
High 0.16 Reference 0.13 0.20
Calf ranch A 0.33 <0.01 0.31 0.36
B 0.12 <0.01 0.10 0.16
C 0.21 Reference 0.18 0.24
1

F-value = 16.16; df = 8; P < 0.0001; and R2 = 0.36.

2

Least squares mean estimate.

3

CI = confidence interval.

4

CS = colostrum supplement (70 g of dried colostrum powder) added to milk replacer; PS = placebo supplement (70 g of nutritionally matched supplement without IgG) added to milk replacer; UC = unsupplemented control.

5

FPT = failure of passive transfer: IgG ≤350 mg/dL; PFPT = partial failure of passive transfer: IgG between (and including) 351 and 999 mg/dL; and APT = adequate passive transfer: IgG ≥1,000 mg/dL.

6

Low: ≤38.5 kg; mid: between 38.6 and 45 kg; high: ≥45 kg.